Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and the increased presence of contract manufacturers globally are among the key ...

Executive SummaryThe biopharma process equipment market is poised for rapid expansion, projected to reach USD 33.2 billion by 2031 from a valuation of USD 11.8 billion in 2023, with a compound annual ...

Contract Development and Manufacturing Organizations (CDMOs) enhance drug discovery by providing essential services that ...